Literature DB >> 3127526

Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.

C Jupin1, S Anderson, C Damais, J E Alouf, M Parant.   

Abstract

We present evidence that toxic shock syndrome toxin 1 (TSST-1) induces the production of high levels of TNF by human blood monocytes. Enriched lymphocyte preparations incubated with the staphylococcal toxin produced significant levels of TNF-like activity that is not neutralized by anti-rHuTNF antibodies and is likely to be lymphotoxin (LT or TNF-beta). We demonstrate also that TSST-1 is a potent inducer of IFN-gamma. When lymphocyte preparations were costimulated with PMA, the TSST-1 effect was strongly potentiated and the levels of cytotoxic factors, IFN-gamma, and IL-2 present in supernatant fluids were comparable to those observed after treatment with PMA and PHA. Thus, TSST-1, which is also known as an inducer of IL-1 and IL-2, stimulates the production of endogenous mediators that could play a role in the physiopathological processes of toxic shock syndrome (TSS). The described results suggest that the discrepancies in the clinical features between TSS and endotoxin shock may be related to qualitative differences in cytokine production.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127526      PMCID: PMC2188868          DOI: 10.1084/jem.167.3.752

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  Endotoxin-like responses induced by staphylococcal enterotoxin.

Authors:  H Sugiyama
Journal:  J Infect Dis       Date:  1966-04       Impact factor: 5.226

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

Review 3.  Toxic shock syndrome: a review.

Authors:  G P Wager
Journal:  Am J Obstet Gynecol       Date:  1983-05-01       Impact factor: 8.661

4.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

6.  Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits.

Authors:  J C de Azavedo; J P Arbuthnott
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

7.  Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome.

Authors:  T Ikejima; C A Dinarello; D M Gill; S M Wolff
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

8.  Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes.

Authors:  N J Poindexter; P M Schlievert
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

9.  Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.

Authors:  T Uchiyama; Y Kamagata; X J Yan; M Kohno; M Yoshioka; H Fujikawa; H Igarashi; M Okubo; F Awano; T Saito-Taki
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

10.  Analysis of the mitogenic effects of toxic shock toxin on human peripheral blood mononuclear cells in vitro.

Authors:  S E Calvano; F W Quimby; A C Antonacci; R F Reiser; M S Bergdoll; P Dineen
Journal:  Clin Immunol Immunopathol       Date:  1984-10
View more
  76 in total

Review 1.  Immune response to staphylococcal superantigens.

Authors:  T Krakauer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Effects of staphylococcal enterotoxins on human neutrophil functions and apoptosis.

Authors:  D A Moulding; C Walter; C A Hart; S W Edwards
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 3.  Bacterial superantigens.

Authors:  T Proft; J D Fraser
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

4.  Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein.

Authors:  M A Tomai; P M Schlievert; M Kotb
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

5.  Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.

Authors:  T Uchiyama; S Saito; H Inoko; X J Yan; K Imanishi; M Araake; H Igarashi
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

6.  Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice.

Authors:  M A Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

7.  Staphylococcal exotoxins stimulate nitric oxide-dependent murine macrophage tumoricidal activity.

Authors:  D J Fast; B J Shannon; M J Herriott; M J Kennedy; J A Rummage; R W Leu
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Overexpression of the T-cell receptor V beta 3 in transgenic mice increases mortality during infection by enterotoxin A-producing Staphylococcus aureus.

Authors:  Y X Zhao; A Abdelnour; T Kalland; A Tarkowski
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).

Authors:  A Norrby-Teglund; D Newton; M Kotb; S E Holm; M Norgren
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Differential induction of tumor necrosis factor alpha in murine and human leukocytes by Mycoplasma arthritidis-derived superantigen.

Authors:  L Rink; W Nicklas; L Alvarez-Ossorio; M Koester; H Kirchner
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.